SBLGX
Price
$66.29
Change
+$0.08 (+0.12%)
Updated
Dec 3 closing price
Net Assets
11.93B
VIGRX
Price
$253.05
Change
+$0.01 (+0.00%)
Updated
Dec 3 closing price
Net Assets
357.2B
Interact to see
Advertisement

SBLGX vs VIGRX

Header iconSBLGX vs VIGRX Comparison
Open Charts SBLGX vs VIGRXBanner chart's image
ClearBridge Large Cap Growth A
Price$66.29
Change+$0.08 (+0.12%)
VolumeN/A
Net Assets11.93B
Vanguard Growth Index Investor
Price$253.05
Change+$0.01 (+0.00%)
VolumeN/A
Net Assets357.2B
SBLGX vs VIGRX Comparison Chart in %
View a ticker or compare two or three
VS
SBLGX vs. VIGRX commentary
Dec 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SBLGX is a Buy and VIGRX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIGRX has more cash in the bank: 357B vs. SBLGX (11.9B). VIGRX pays higher dividends than SBLGX: VIGRX (0.30) vs SBLGX (0.00). SBLGX was incepted earlier than VIGRX: SBLGX (28 years) vs VIGRX (33 years). SBLGX (1.01) is less costly to investors than VIGRX (0.17). SBLGX is a more actively managed with annual turnover of: 16.00 vs. VIGRX (11.00). SBLGX has a lower initial minimum investment than VIGRX: SBLGX (1000) vs VIGRX (3000). VIGRX annual gain was more profitable for investors over the last year : 18.49 vs. SBLGX (-1.94). VIGRX return over 5 years is better than : 99.11 vs. SBLGX (5.66).
SBLGXVIGRXSBLGX / VIGRX
Total Expense Ratio1.010.17594%
Annual Report Gross Expense Ratio1.010.17594%
Fund Existence28 years33 years-
Gain YTD6.33619.76432%
Front Load6%N/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets11.9B357B3%
Annual Yield % from dividends0.000.30-
Returns for 1 year-1.9418.49-10%
Returns for 3 years42.80110.8239%
Returns for 5 years5.6699.116%
Returns for 10 years95.13349.1327%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
STOK30.961.15
+3.86%
Stoke Therapeutics
NEPH5.400.09
+1.69%
Nephros
TACO10.15N/A
N/A
Berto Acquisition Corp
HVIIU10.60N/A
N/A
Hennessy Capital Investmnt Corp VII
AHR50.31-0.13
-0.26%
American Healthcare REIT